Abstract:The pool of microbes inhabiting our body is known as "microbiota" and their collective genomes as "microbiome". The colon is the most densely populated organ in the human body, although other parts, such as the skin, vaginal mucosa, or respiratory tract, also harbour specific microbiota. This microbial community regulates some important metabolic and physiological functions of the host, and drives the maturation of the immune system in early life, contributing to its homeostasis during life. Alterations of the intestinal microbiota can occur by changes in composition (dysbiosis), function, or microbiota-host interactions and they can be directly correlated with several diseases. The only disease in which a clear causal role of a dysbiotic microbiota has been demonstrated is the case of Clostridium difficile infections. Nonetheless, alterations in composition and function of the microbiota have been associated with several gastrointestinal diseases (inflammatory bowel disease, colorectal cancer, or irritable bowel syndrome), as well as extra-intestinal pathologies, such as those affecting the liver, or the respiratory tract (e.g., allergy, bronchial asthma, and cystic fibrosis), among others. Species of Bifidobacterium genus are the normal inhabitants of a healthy human gut and alterations in number and composition of their populations is one of the most frequent features present in these diseases. The use of probiotics, including bifidobacteria strains, in preventive medicine to maintain a healthy intestinal function is well documented. Probiotics are also proposed as therapeutic agents for gastrointestinal disorders and other pathologies. The World Gastroenterology Organization recently published potential clinical applications for several probiotic formulations, in which species of lactobacilli are predominant. This review is focused on probiotic preparations containing Bifidobacterium strains, alone or in combination with other bacteria, which have been tested in human clinical studies. In spite of extensive literature on and research into this topic, the degree of scientific evidence of the effectiveness of probiotics is still insufficient in most cases. More effort need to be made to design and conduct accurate human studies demonstrating the efficacy of probiotics in the prevention, alleviation, or treatment of different pathologies.

Gut Bacteroides species in health and disease

Bacteroides and related species: The keystone taxa of the human gut microbiota

Roles of intestinal bacteroides in human health and diseases

Microbial interactions and the homeostasis of the gut microbiome: the role of Bifidobacterium

Exploring Bacteroidetes: Metabolic key points and immunological tricks of our gut commensals

Bacteroides thetaiotaomicron in the gut: Molecular aspects of their interaction

Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis

Environmental and Gut Bacteroidetes: The Food Connection

The Gut Core Microbial Species Bifidobacterium Longum: Colonization, Mechanisms, and Health Benefits

Genomics and ecological overview of the genus Bifidobacterium

Impacts of Gut Bacteria on Human Health and Diseases

Molecular Diversity of Bacteroides Spp. in Human Fecal Microbiota As Determined by Group-Specific 16s Rrna Gene Clone Library Analysis

Good or bad: gut bacteria in human health and diseases

Bacteroides utilization for dietary polysaccharides and their beneficial effects on gut health

Part 1: The Human Gut Microbiome in Health and Disease

A Closer Look at Bacteroides: Phylogenetic Relationship and Genomic Implications of a Life in the Human Gut

Unraveling the Metabolic Requirements of the Gut Commensal Bacteroides ovatus

Review Article: Gut Microbiota as Biological Regulators for Human Health

A potential species of next-generation probiotics? The dark and light sides of Bacteroides fragilis in health

Enterobacteriaceae in the Human Gut: Dynamics and Ecological Roles in Health and Disease

The Bacterial Connection between the Oral Cavity and the Gut Diseases